Real-time enrollment status for this epilepsy, generalized clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:35 AM UTC
| NCT Number | NCT06769659 |
| Recruiting Status | Recruiting |
| Condition | Epilepsy, Generalized |
| Phase | PHASE2 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | NeuroPro Therapeutics, Inc. |
| Last Updated on CT.gov | May 29, 2026 (May 29, 2026) |
As of July 19, 2026: Clinical trial NCT06769659 is currently recruiting participants. This phase2 study for epilepsy, generalized is actively seeking new participants at 1 location across the United States. The study is sponsored by NeuroPro Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06769659 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06769659 was last updated May 29, 2026 (May 29, 2026). HelloStudys verifies this status automatically.